| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414347A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2412845A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 01/10/2002 | CA2412775A1 Antibodies to human mcp-1 |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410551A1 Heterodimeric fusion proteins |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170592A1 Presentation of hydrophobic antigens to T-cells by CD1 molecules |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170367A1 BVDV virus-like particles |
| 01/09/2002 | EP1170017A1 Use of tumor necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor (VEGF) for the manufacture of a therapeutic composition |
| 01/09/2002 | EP1170016A2 Urease-based vaccine against helicobacter infection |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169465A1 Two-step immunization procedure against chlamydia infection |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169453A1 Inhibition of viral infection using monovalent antigen-binding proteins |
| 01/09/2002 | EP1169452A1 Viral variants |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169450A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/09/2002 | EP1169449A2 Clasp-2 transmembrane proteins |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169353A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 01/09/2002 | EP1169352A1 Erythropoietin receptor antibodies |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169341A1 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169066A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 01/09/2002 | EP1169059A1 Docetaxel in combination with rhumab her2 for the treatment of cancers |
| 01/09/2002 | EP1169057A2 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1169044A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 01/09/2002 | EP1169021A1 Compositions and methods for treating lymphoma |
| 01/09/2002 | EP1168923A1 Dna vaccination for treatment of autoimmune disease |
| 01/09/2002 | EP1168918A1 Vaccines and gene therapy compositions and methods of making and using the same |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0728146B1 Conotoxin peptides |
| 01/09/2002 | EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 01/09/2002 | EP0683671B1 Immune system modulation using psoralens activated with visible light |
| 01/09/2002 | EP0618813B1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330718A Therapeutically active proteins in plants |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330712A Biogical compositions, components thereof and uses therefor |
| 01/09/2002 | CN1330662A Heliobacter pylori antigen |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1330554A Chimeric anti-CD20 antibody treatment of paitients receiving BMT or PBSC transplants |
| 01/09/2002 | CN1330553A Adjuvant systems and vaccines |
| 01/09/2002 | CN1330552A Oral vaccine against diarrhea |
| 01/09/2002 | CN1330081A Single-chain antibody resisting HIV-1 outer membrane protein and recombinant immunotoxin |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/08/2002 | US6337179 Methods and kits for detecting antibodies against an HIV variant |
| 01/08/2002 | US6337075 Methods for treating diabetes |
| 01/08/2002 | US6337073 Administering intranasally a live, attenuated yellow fever virus to a human for inducing a binding and a neutralizing antibody response to provide immunity |
| 01/08/2002 | US6337070 Polypeptides for use in generating anti-human influenza virus antibodies |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2092905C Treatment of autoimmune diseases by oral administration of autoantigens |
| 01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/08/2002 | CA1341332C Method for obtaining protective antigens against bordetella infections and toxic processes |
| 01/03/2002 | WO2002000892A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 01/03/2002 | WO2002000888A1 Helicobacter pylori heptosyl transferase polypeptides |
| 01/03/2002 | WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 01/03/2002 | WO2002000883A2 Rescue of canine distemper virus from cdna |
| 01/03/2002 | WO2002000882A2 Transport peptides dirived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
| 01/03/2002 | WO2002000881A1 Bvdv virus-like particles |
| 01/03/2002 | WO2002000868A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | WO2002000867A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 01/03/2002 | WO2002000862A2 32447, a novel human acyltransferase and uses thereof |
| 01/03/2002 | WO2002000851A2 Helicobacter dd-heptosyltransferase |
| 01/03/2002 | WO2002000844A2 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/03/2002 | WO2002000730A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000725A2 G-protein coupled receptor org10 |
| 01/03/2002 | WO2002000711A2 Ev-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | WO2002000708A2 Mutants of prostase |
| 01/03/2002 | WO2002000702A2 Regulation of human epidermis-specific serine protease |
| 01/03/2002 | WO2002000695A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
| 01/03/2002 | WO2002000694A2 Modified morbillivirus v proteins |
| 01/03/2002 | WO2002000693A2 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 01/03/2002 | WO2002000692A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | WO2002000662A1 Improvements in and relating to chromophores |
| 01/03/2002 | WO2002000266A2 A method of treating and preventing infectious diseases |